ULTRAGENYX EUROPE GMBH
502078-5456ActiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Oversigt
- 1–4
- Medarbejdere
- Ukendt
- Omsætning
- 2022
- Grundlagt
Nøglebeslutningstagere
Emil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Beskrivelse
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Ukendt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502078545601
Beslutningstagere
2 kontakter i FunnelfeedrEmil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrBridgeBio International GmbH
1–4 medarbejdereDeveloping transformative medicines for rare genetic conditions quickly.
SAREPTA THERAPEUTICS, INC.
0 medarbejdereEngineering precision genetic medicine to rescue lives from rare diseases.
OxThera Intellectual Property AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Orchard Therapeutics (Sweden) AB
1–4 medarbejdereDeveloping life-transforming HSC gene therapies for severe genetic diseases.
AMICUS THERAPEUTICS LTD
1–4 medarbejdereGlobal biotechnology company developing transformative medicines for rare diseases.
Udforsk mere
Spørgsmål om ULTRAGENYX EUROPE GMBH
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo